Exhibit 107
Calculation of Filing Fee Tables
Form F-3
(Form Type)
ALTERITY THERAPEUTICS LIMITED.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price (1) | Fee Rate | Amount of Registration Fee | |||||||||||||||||||
Fees to Be Paid | Equity | Ordinary shares, no par value per share | ||||||||||||||||||||||||
Other | Warrants | |||||||||||||||||||||||||
Other | Units | |||||||||||||||||||||||||
Unallocated (Universal) Shelf | Unallocated (Universal) Shelf | 457(o) | (2) | (3) | $ | 50,000,000 | 0.0001102 | $ | 5,510.00 | |||||||||||||||||
Total Offering Amounts | $ | 5,510.00 | ||||||||||||||||||||||||
Total Fees Previously Paid | - | |||||||||||||||||||||||||
Total Fee Offsets | $ | 3,839 | ||||||||||||||||||||||||
Net Fee Due | $ | 1671.00 |
(1) | The proposed maximum aggregate offering price per class of security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to instructions to Form F-3 under the Securities Act, as amended, or the Securities Act. |
(2) | There are being registered hereunder such indeterminate number of the securities of each identified class being registered as may be sold by the registrant from time to time at indeterminate prices, with the maximum aggregate public offering price not to exceed $50,000,000. Also includes such indeterminate number of securities of the registrant as may be issued upon exercise, conversion or exchange of these securities. Separate consideration may or may not be received for securities that are issuable upon exercise, conversion or exchange of other securities. |
(3) | The proposed maximum aggregate price per unit of each class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of securities pursuant to the General Instruction II.C. of Form F-3 under the Securities Act of 1933. |
Table 2: Fee Offset Claims and Sources
Registrant or Filer Name | Form or Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset Claimed | Security Type Associated with Fee Offset Claimed | Security Title Associated with Fee Offset Claimed | Unsold Securities Associated with Fee Offset Claimed | Unsold Aggregate Offering Amount Associated with Fee Offset Claimed | Fee Paid with Fee Offset Source | ||||||||||||||||||
Rule 457(p) | ||||||||||||||||||||||||||||
Fee Offset Claims | ALTERITY THERAPEUTICS LIMITED | F-3 | 333-249311 (4) | October 5, 2020 | N/A | $ | 1,212 | Equity | Ordinary Shares | N/A | $ | 34,843,106 | N/A | |||||||||||||||
Fee Offset Sources | ALTERITY THERAPEUTICS LIMITED | F-3 | 333-249311 (4) | N/A | October 9, 2020 | N/A | N/A | N/A | N/A | N/A | $ | 3,839 |
(4) | Attributable to $34,843,106 of unsold securities ($3,839 of previously paid fees) that were previously registered under the Registration Statement on Form F-3 (333-249311) on October 9, 2020 (the “Prior Registration Statement”) that have not yet been issued and sold. Pursuant to Rule 457(p) under the Securities Act, such unutilized filing fees may be applied to the filing fees payable pursuant to this Registration Statement, and the Prior Registration Statement and the offering of the unsold securities registered under the Prior Registration Statement will be deemed terminated as of the effective date of this Registration Statement. |